Tinlarebant (LBS-008)

Name: Tinlarebant (LBS-008) in Stargardt disease type 1: Definition and etiology
Published: 2026-09-14T15:39:06-04:00

Stargardt disease type 1

Manufacturer: Belite Bio
Regulatory submission: NDA submitted June 2026
Launch: Anticipated in March 2027
Last updated: September 19, 2026

Section

Product information and disease description Place of product in therapy Disease description

Definition and etiology

2 evidence topics · 2 sources

Inherited retinal disease

“Stargardt disease is a rare genetic eye disease” (opens the source at this quote in a new tab)

ABCA4 and vitamin A handling

“Stargardt disease is usually caused by changes in a gene called ABCA4. This gene affects how your body uses vitamin A.” (opens the source at this quote in a new tab)